Agilent Technologies Files 8-K/A Amendment
Ticker: A · Form: 8-K/A · Filed: Apr 4, 2026 · CIK: 0001090872
Sentiment: neutral
Topics: amendment, officer-changes, exhibits
TL;DR
Agilent filed an 8-K/A amendment on 4/6/26 covering officer/director changes and financials.
AI Summary
Agilent Technologies, Inc. filed an 8-K/A amendment on April 6, 2026, related to the period ending March 31, 2026. The filing specifically addresses Item 5.02 concerning the departure or election of officers and directors, as well as Item 9.01 regarding financial statements and exhibits. No specific names or dollar amounts were detailed in the provided excerpt.
Why It Matters
This amendment to a previous filing provides updated or corrected information regarding executive and director changes or compensation, and potentially includes new financial statements or exhibits for Agilent Technologies.
Risk Assessment
Risk Level: low — The filing is an amendment to a previous report and does not appear to disclose new material adverse events.
Key Players & Entities
- AGILENT TECHNOLOGIES, INC. (company) — Filer
- 0001090872 (company) — CIK number for Agilent Technologies, Inc.
- 2026-04-06 (date) — Filing Date
- 2026-03-31 (date) — Period of Report
FAQ
What specific changes are being reported under Item 5.02 in this 8-K/A filing?
The filing indicates it pertains to Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers, but the specific details of these changes are not provided in the excerpt.
What is the purpose of filing an 8-K/A?
An 8-K/A is an amendment to a previously filed 8-K report, used to correct or update information previously disclosed.
What is the filing date of this 8-K/A amendment?
The filing date is April 6, 2026.
What period does this filing cover?
The period of report is March 31, 2026.
Are there any financial statements or exhibits included with this filing?
Yes, Item 9.01 indicates that Financial Statements and Exhibits are included, with specific documents like 'a-20260331.htm' and 'a-ex10_1.htm' listed.
Filing Stats: 776 words · 3 min read · ~3 pages · Grade level 12 · Accepted 2026-04-03 21:30:08
Key Financial Figures
- $0.01 — nge on which registered Common Stock, $0.01 par value A New York Stock Exchange
- $350,000 — a base salary at the annualized rate of $350,000, will remain eligible to participate in
Filing Documents
- a-20260331.htm (8-K/A) — 50KB
- a-ex10_1.htm (EX-10.1) — 274KB
- 0001193125-26-142673.txt ( ) — 465KB
- a-20260331.xsd (EX-101.SCH) — 24KB
- a-20260331_htm.xml (XML) — 5KB
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 10.1 Transition and General Release Agreement between Bret DiMarco and Agilent Technologies, Inc., dated March 31, 2026 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Agilent Technologies, Inc. Date: April 3, 2026 By: /s/ Padraig McDonnell Padraig McDonnell President and Chief Executive Officer